{"result": {"id": "7469cdbe-1dbd-4c8a-bd74-846d324f865c", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Non-Fibrate and Related Lipid-Lowering Agents Community\",\n    \"summary\": \"This community is centered around Non-Fibrate and related lipid-lowering agents, including Fenofibrate, Ciprofibrate, Gemfibrozil, Bezafibrate, and others, which are primarily used for treating hypertriglyceridemia and mixed hyperlipidemia. These entities are interconnected through their pharmacological class, therapeutic uses, and shared adverse effects, highlighting a network of drugs with similar mechanisms of action and clinical applications.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the widespread use of these drugs in managing lipid disorders and their potential for significant adverse effects.\",\n    \"findings\": [\n        {\n            \"summary\": \"Fenofibrate as a central entity\",\n            \"explanation\": \"Fenofibrate stands out as a central entity within this community, being highly connected to other lipid-lowering agents through shared therapeutic uses and mechanisms. It is specifically noted for its efficacy in treating hypertriglyceridemia, with a well-documented profile of use and safety. [Data: Entities (2310), Relationships (1711, 2491, 1991, 2020)]\"\n        },\n        {\n            \"summary\": \"Shared therapeutic applications\",\n            \"explanation\": \"The community members share common therapeutic applications, particularly in the treatment of hypertriglyceridemia and mixed hyperlipidemia. This shared purpose underscores the importance of these agents in managing lipid disorders and their collective impact on patient care. [Data: Relationships (1711, 2491, 1991, 2002, 2023)]\"\n        },\n        {\n            \"summary\": \"Adverse effects and safety profiles\",\n            \"explanation\": \"A notable aspect of this community is the shared adverse effects among its members, including gastrointestinal discomfort, liver enzyme elevations, and others. These shared risks highlight the need for careful monitoring when prescribing these medications. [Data: Entities (2310, 2598, 2599), Relationships (2020, 2023, 2024)]\"\n        },\n        {\n            \"summary\": \"Pharmacological class and mechanisms\",\n            \"explanation\": \"The agents in this community belong to the fibrate class or related categories, acting primarily through the activation of PPAR receptors to lower triglyceride levels. This shared mechanism of action is a key factor in their therapeutic efficacy and potential for drug interactions. [Data: Entities (2310, 2392, 2391, 2390), Relationships (2491, 1991, 2002)]\"\n        },\n        {\n            \"summary\": \"Special considerations for diabetes patients\",\n            \"explanation\": \"Certain members of this community, such as Acipimox and Bezafibrate, are noted for their additional benefits in diabetic patients, including effects on glucose metabolism. This makes them particularly valuable in the management of lipid disorders in diabetic populations. [Data: Entities (2389, 2390), Relationships (2002)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1753518472, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 652, "prompt_tokens": 3620, "total_tokens": 4272, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 2148}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n2310,非诺贝特,\"**非诺贝特**是一种贝特类药物，化学名称为普鲁脂芬，商品名包括立平脂、苯酰降酯内酯等，主要用于降脂治疗，尤其适用于以三酰甘油（甘油三酯）升高为主的高脂血症。作为治疗高三酰甘油血症的首选药物，其作用机制主要为显著降低血液中的三酰甘油水平。  \n\n非诺贝特的常规剂量为0.1克/次，每日2次，但停药后可能出现血脂反弹现象。该药物不良反应较少，但部分患者可能出现胃肠道不适、食欲减退、嗳气、皮疹、白细胞减少或暂时性肝转氨酶升高等症状。相较于其他降脂药物，非诺贝特对UGT（尿苷二磷酸葡萄糖醛酸转移酶）和CYP2C8（细胞色素P450 2C8酶）无抑制作用，因此药物相互作用极少见，临床安全性较高。  \n\n综合来看，非诺贝特是一种高效且耐受性良好的降脂药物，尤其适用于三酰甘油升高的患者，但需注意其潜在不良反应及停药后可能出现的血脂反弹问题。\",10\r\n2392,环丙贝特,\"环丙贝特是一种苯氧芳酸类（或贝特类）药物，主要用于调节血脂，特别是治疗高甘油三酯血症（高TG血症）。作为贝特类药物的一种，环丙贝特通过激活过氧化物酶体增殖物激活受体（PPAR）来降低血液中的甘油三酯水平，同时可能对胆固醇代谢产生调节作用。其药理作用与其他贝特类药物相似，适用于血脂异常患者，尤其是以甘油三酯升高为主要特征的患者。  \n\n环丙贝特的临床应用侧重于改善脂质代谢紊乱，但其具体作用机制和适应症可能因个体情况而有所差异。综合来看，该药物在降血脂领域具有明确疗效，尤其针对高TG血症患者。\",3\r\n2582,诺衡,\"诺衡是一种贝特类药物，用于降低三酰甘油，是治疗高三酰甘油血症的首选药物\"\"\",1\r\n2598,氯贝特,氯贝特是一种药物，也称为氯贝丁酯、氯苯丁酯、安妥明、降脂乙脂、祛脂乙酯、冠心平，用于降脂治疗，可能引起胃肠道不适、白细胞减少、斑状脱发、头昏、皮疹、肝功能异常、肌无力、肌痉挛、胸痛等不良反应,1\r\n2391,吉非贝齐,吉非贝齐（诺衡）是一种苯氧芳酸类（或贝特类）药物，主要用于调节血脂，治疗高三酰甘油血症和混合型高脂血症。作为贝特类药物的代表之一，它通过降低血液中的三酰甘油水平和调节脂蛋白代谢来发挥作用。尽管不同描述中对其药物类别的表述略有差异（苯氧芳酸类或贝特类），但两者本质上是相关的，因为苯氧芳酸衍生物是贝特类药物的主要组成部分。因此，吉非贝齐的临床应用和药理作用是一致的，即作为降脂药物用于特定类型的高脂血症患者。,4\r\n2390,苯扎贝特,苯扎贝特（又称必降脂）是一种苯氧芳酸类或贝特类药物，主要用于治疗高三酰甘油血症（高TG血症）和混合型高脂血症。该药物特别适用于伴有血凝倾向增高的患者，通过调节血脂水平发挥治疗作用。作为贝特类药物的代表，苯扎贝特通过降低血液中的三酰甘油（TG）浓度来改善脂质代谢异常，同时可能对胆固醇水平产生一定影响。其药理作用与其他苯氧芳酸衍生物类似，通过激活过氧化物酶体增殖物激活受体（PPAR）来调节脂蛋白代谢。苯扎贝特的临床应用侧重于以三酰甘油升高为主的脂代谢紊乱，并在特定情况下用于预防血栓形成风险增高的相关并发症。,6\r\n2600,消胆胺,消胆胺是一种药物，也称为消胆胺脂、考来烯胺，长期服用可引起脂肪吸收不良，应适当补充维生素A、维生素K、维生素D及钙盐,2\r\n2389,阿西莫司,\"阿西莫司（又称氧甲吡嗪、乐脂平）是一种烟酸类降脂药物，主要用于治疗高三酰甘油血症、混合型高脂血症以及高胆固醇血症。该药物特别适用于糖尿病继发的血脂异常患者，通过调节血脂水平发挥作用。其常见剂量为250毫克（标注中“园援圆缘克”为“250克”的误写，实际应为毫克单位）。  \n\n作为烟酸衍生物，阿西莫司通过抑制脂肪组织分解、减少游离脂肪酸释放，从而降低肝脏极低密度脂蛋白（VLDL）的合成，最终达到降低三酰甘油和胆固醇的效果。不同描述中提到的适应症（如高三酰甘油血症、混合型高脂血症、高胆固醇血症）并无矛盾，而是反映了其多靶点作用机制。别称“乐脂平”为商品名，“氧甲吡嗪”则为化学名或通用名变体。  \n\n综上，阿西莫司是一种多效降脂药，核心功能涵盖血脂异常的主要类型，尤其针对糖尿病相关代谢紊乱，临床使用需遵循具体剂量规范。\",1\r\n2599,阿昔莫司,阿昔莫司是一种药物，也称为乐脂平、吡莫酸、氧甲吡嗪，用于降脂治疗，可能引起皮肤红斑、热感和瘙痒，偶见有上腹部不适、头痛、乏力等不良反应,2\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n1711,非诺贝特,高脂血症,非诺贝特用于治疗以三酰甘油升高为主的高脂血症。,120\r\n2491,非诺贝特,环丙贝特,非诺贝特和环丙贝特都是贝特类药物，主要用于治疗高TG血症,13\r\n1991,非诺贝特,诺衡,非诺贝特和诺衡都属于贝特类药物，用于降低三酰甘油,11\r\n2020,氯贝特,非诺贝特,氯贝特和非诺贝特都是降脂药物，具有相似的不良反应和禁忌症,11\r\n2023,吉非贝齐,苯扎贝特,吉非贝齐和苯扎贝特都是降脂药物，具有相似的不良反应和禁忌症,10\r\n2024,苯扎贝特,消胆胺,苯扎贝特和消胆胺都是降脂药物，具有相似的不良反应和禁忌症,8\r\n2002,阿西莫司,苯扎贝特,\"阿西莫司和苯扎贝特是两种用于治疗代谢性疾病的药物，主要针对高三酰甘油血症和混合型高脂血症，尤其适用于继发于糖尿病的患者。这两种药物均具有降低空腹血糖的作用，同时也能有效调节血脂水平，改善患者的代谢状况。  \n\n阿西莫司和苯扎贝特的作用机制虽不完全相同，但均能通过不同的途径减少血液中的三酰甘油含量，从而降低心血管疾病的风险。此外，它们对糖尿病患者的血糖控制也有辅助效果，使其成为治疗糖尿病相关脂代谢异常的重要选择。  \n\n综合来看，阿西莫司和苯扎贝特在临床应用中既可用于调节血脂，又能改善血糖水平，尤其适合同时患有高脂血症和糖尿病的患者。\",7\r\n2022,阿昔莫司,吉非贝齐,阿昔莫司和吉非贝齐都是降脂药物，具有相似的不良反应和禁忌症,6\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_04c20fa3a0dd04e4e61442bbe8465eb3d7ae30c9545d59640d315c7613b14fc3_v2"}